389
Views
10
CrossRef citations to date
0
Altmetric
Original Article

The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease

, , , , &
Pages 846-850 | Received 06 Feb 2017, Accepted 01 Apr 2017, Published online: 20 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ying Cao, Yibei Dai, Lingyu Zhang, Danhua Wang, Wen Hu, Qiao Yu, Xuchu Wang, Pan Yu, Weiwei Liu, Ying Ping, Tao Sun, Yiwen Sang, Zhenping Liu, Yan Chen & Zhihua Tao. (2021) Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin. Journal of Inflammation Research 14, pages 6409-6419.
Read now

Articles from other publishers (9)

Natasha Haskey, Mehrbod Estaki, Jiayu Ye, Rachel K Shim, Sunny Singh, Levinus A Dieleman, Kevan Jacobson & Deanna L Gibson. (2023) A Mediterranean Diet Pattern Improves Intestinal Inflammation Concomitant with Reshaping of the Bacteriome in Ulcerative Colitis: A Randomised Controlled Trial. Journal of Crohn's and Colitis 17:10, pages 1569-1578.
Crossref
Giuseppe Solarino, Davide Bizzoca, Lorenzo Moretti, Giovanni Vicenti, Andrea Piazzolla & Biagio Moretti. (2022) What’s New in the Diagnosis of Periprosthetic Joint Infections: Focus on Synovial Fluid Biomarkers. Tropical Medicine and Infectious Disease 7:11, pages 355.
Crossref
Davide Bizzoca, Lorenzo Moretti, Antonio Gnoni, Francesco Luca Moretti, Salvatore Scacco, Giuseppe Banfi, Andrea Piazzolla, Giuseppe Solarino & Biagio Moretti. (2022) The Usefulness of Synovial Fluid Proteome Analysis in Orthopaedics: Focus on Osteoarthritis and Periprosthetic Joint Infections. Journal of Functional Morphology and Kinesiology 7:4, pages 97.
Crossref
Konstantinos Makrilakis, Aikaterini Barmpagianni & Maria Veiga-da-Cunha. (2022) Repurposing of Empagliflozin as a Possible Treatment for Neutropenia and Inflammatory Bowel Disease in Glycogen Storage Disease Type Ib: A Case Report. Cureus.
Crossref
Chenthan Krishnakumar, Ashwin N. Ananthakrishnan, Brendan M. Boyle, Anne M. Griffiths, Neal S. LeLeiko, David R. Mack, James F. Markowitz, Joel R. Rosh, Cary G. Sauer, Thomas D. Walters, Erin Bonkowski, Lee A. Denson, Jeffrey S. Hyams & Subra Kugathasan. (2021) Early Change in Fecal Calprotectin Predicts One‐Year Outcome in Children Newly Diagnosed With Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition 74:1, pages 72-78.
Crossref
Steve Halligan, Darren Boone, Lucinda Archer, Tariq Ahmad, Stuart Bloom, Manuel Rodriguez-Justo, Stuart A Taylor & Sue Mallett. (2021) Prognostic biomarkers to identify patients likely to develop severe Crohn’s disease: a systematic review. Health Technology Assessment 25:45, pages 1-66.
Crossref
Trifa Mahmood, Mohammed Mohammed, Dana Gharib, Taha Mohamad, Muhsin Mohammed & Araz Rahim. (2021) ROLE OF FECAL CALPROTECTIN IN DIFFERENTIATION OF INFLAMMATORY BOWEL DISEASES IN PATIENTS COMPLAINING OF ABDOMINAL SYMPTOMS AND REFERRED FOR COLONOSCOPY. JOURNAL OF SULAIMANI MEDICAL COLLEGE 11:1, pages 33-44.
Crossref
Parambir S. Dulai, Laurent Peyrin-Biroulet, Silvio Danese, Bruce E. Sands, Axel Dignass, Dan Turner, Gerassimos Mantzaris, Juergen Schölmerich, Jean-Yves Mary, Walter Reinisch & William J. Sandborn. (2019) Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases. Gastroenterology 157:4, pages 1032-1043.e1.
Crossref
Xu Teng, Cuiyun Gao, Mei Sun & Jie Wu. (2017) Clinical significance of fecal calprotectin for the early diagnosis of abdominal type of Henoch–Schonlein purpura in children. Clinical Rheumatology 37:6, pages 1667-1673.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.